Calciphylaxis in hemodialysis

  • Liliana Andrade Servicio de Nefrología, Hospital Médico Policial Churruca-Visca, Buenos Aires
  • Edgardo Mojico Servicio de Nefrología, Hospital Médico Policial Churruca-Visca, Buenos Aires
  • María Inés García Servicio de Nefrología, Hospital Médico Policial Churruca-Visca, Buenos Aires
  • Marcelo Serrano Servicio de Nefrología, Hospital Médico Policial Churruca-Visca, Buenos Aires
  • Mabel Fogliati Servicio de Nefrología, Hospital Médico Policial Churruca-Visca, Buenos Aires
  • Ricardo Martínez Servicio de Nefrología, Hospital Médico Policial Churruca-Visca, Buenos Aires

References

Torregrosa JV, Bover J, Cannata Andía J, Lorenzo V, De Francisco AL, Martínez I, et al. Spanish Society of Nephrology recommendations for controlling mineral and bone disorder in chronic kidney disease patients (S.E.N.-M.B.D.). Nefrología. 2011;31 Suppl 1:3-32.

Sood AR, Wazny LD, Raymond CB, Leung K, Komenda P, Reslerova M, et al. Sodium thiosulfate-based treatment in calcific uremic arteriolopathy: a consecutive case series. Clin Nephrol. 2011;75(1):8-15.

Ng AT, Peng DH. Calciphylaxis. Dermatol Ther. 2011;24(2):256-62.

Budisavljevic MN, Cheek D, Ploth DW. Calciphylaxis in chronic renal failure. J Am Soc Nephrol. 1996;7(7):978-82.

Smiley CM, Hanlon SU, Michel DM. Calciphylaxis in moderate renal insufficiency: changing disease concepts. Am J Nephrol. 2000;20(4):324-8.

Weenig RH, Sewell LD, Davis MD, McCarthy JT, Pittelkow MR. Calciphylaxis: natural history, risk factor analysis, and outcome. J Am Acad Dermatol. 2007;56(4):569-79.

Published
2015-06-01
How to Cite
1.
Andrade L, Mojico E, García MI, Serrano M, Fogliati M, Martínez R. Calciphylaxis in hemodialysis. Rev Nefrol Dial Traspl. [Internet]. 2015Jun.1 [cited 2024Jul.16];35(2):119-20. Available from: http://revistarenal.org.ar/index.php/rndt/article/view/28
Issue
Vol. 35 No. 2 (2015): Abr.-Jun.
Section
Images in Nephrology